Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Citi
Deloitte
Julphar
Fish and Richardson
QuintilesIMS

Generated: March 22, 2019

DrugPatentWatch Database Preview

SODIUM IODIDE I-131 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sodium iodide i-131 and what is the scope of sodium iodide i-131 freedom to operate?

Sodium iodide i-131 is the generic ingredient in three branded drugs marketed by Bracco, CIS, Jubilant Draximage, and Mallinkrodt Nuclear, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and seventy-two drug master file entries for sodium iodide i-131. One supplier is listed for this compound.

Summary for SODIUM IODIDE I-131
Pharmacology for SODIUM IODIDE I-131

US Patents and Regulatory Information for SODIUM IODIDE I-131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cis SODIUM IODIDE I 131 sodium iodide i-131 SOLUTION;ORAL 017315-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Draximage HICON sodium iodide i-131 SOLUTION;ORAL 021305-005 Apr 4, 2006 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Draximage HICON sodium iodide i-131 SOLUTION;ORAL 021305-002 Jan 24, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco IODOTOPE sodium iodide i-131 CAPSULE;ORAL 010929-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Draximage HICON sodium iodide i-131 SOLUTION;ORAL 021305-003 Jan 24, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Jubilant Draximage SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 021305-006 May 19, 2005 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Citi
Chinese Patent Office
Daiichi Sankyo
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.